{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:48:47Z","timestamp":1792097327679,"version":"4.4.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"DOI":"10.1007\/s12032-026-03363-x","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T05:25:16Z","timestamp":1789449916000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Nanotheranostics armed with folate: an integrated approach for precision targeting of glioblastoma"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8021-1702","authenticated-orcid":false,"given":"Dipak B.","family":"Bari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7264-0603","authenticated-orcid":false,"given":"Chandrakantsing V.","family":"Pardeshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,15]]},"reference":[{"issue":"11","key":"3363_CR1","doi-asserted-by":"publisher","first-page":"6000","DOI":"10.1021\/acsbiomaterials.9b00856","volume":"5","author":"R Afzalipour","year":"2019","unstructured":"Afzalipour R, Khoei S, Khoee S, Shirvalilou S, Jamali Raoufi N, Motevalian M, et al. Dual-targeting temozolomide loaded in folate-conjugated magnetic triblock copolymer nanoparticles to improve the therapeutic efficiency of rat brain gliomas. ACS Biomater Sci Eng. 2019;5(11):6000\u201311. https:\/\/doi.org\/10.1021\/acsbiomaterials.9b00856.","journal-title":"ACS Biomater Sci Eng"},{"issue":"21","key":"3363_CR2","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.3390\/nano12213869","volume":"12","author":"NC Allen","year":"2022","unstructured":"Allen NC, Chauhan R, Bates PJ, O\u2019Toole MG. Optimization of tumor targeting gold nanoparticles for glioblastoma applications. Nanomaterials (Basel). 2022;12(21):3869. https:\/\/doi.org\/10.3390\/nano12213869.","journal-title":"Nanomaterials (Basel)"},{"issue":"3","key":"3363_CR3","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.jconrel.2011.06.001","volume":"153","author":"YH Bae","year":"2011","unstructured":"Bae YH, Park K. Targeted drug delivery to tumors: myths, reality and possibility. J Control Release. 2011;153(3):198\u2013205. https:\/\/doi.org\/10.1016\/j.jconrel.2011.06.001.","journal-title":"J Control Release"},{"issue":"8","key":"3363_CR4","doi-asserted-by":"publisher","first-page":"5727","DOI":"10.1007\/s13277-015-3706-6","volume":"36","author":"B Bahrami","year":"2015","unstructured":"Bahrami B, Mohammadnia-Afrouzi M, Bakhshaei P, Yazdani Y, Ghalamfarsa G, Yousefi M, et al. Folate-conjugated nanoparticles as a potent therapeutic approach in targeted cancer therapy. Tumour biol. 2015;36(8):5727\u201342. https:\/\/doi.org\/10.1007\/s13277-015-3706-6.","journal-title":"Tumour biol"},{"issue":"14","key":"3363_CR5","doi-asserted-by":"publisher","first-page":"4218","DOI":"10.1039\/c6cs00636a","volume":"46","author":"S Behzadi","year":"2017","unstructured":"Behzadi S, Serpooshan V, Tao W, Hamaly MA, Alkawareek MY, Dreaden EC, et al. Cellular uptake of nanoparticles: journey inside the cell. Chem Soc Rev. 2017;46(14):4218\u201344. https:\/\/doi.org\/10.1039\/c6cs00636a.","journal-title":"Chem Soc Rev"},{"issue":"8","key":"3363_CR6","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1038\/s41556-022-00967-z","volume":"24","author":"MC Beytagh","year":"2022","unstructured":"Beytagh MC, Weiss WA. EGFR ligands dictate tumour suppression. Nat Cell Biol. 2022;24(8):1189\u201391. https:\/\/doi.org\/10.1038\/s41556-022-00967-z.","journal-title":"Nat Cell Biol"},{"issue":"1","key":"3363_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000536186","volume":"9","author":"AC Branco","year":"2024","unstructured":"Branco AC, Rogers LM, Aronoff DM. Folate receptor beta signaling in the regulation of macrophage antimicrobial immune response: a scoping review. Biomed Hub. 2024;9(1):31\u20137. https:\/\/doi.org\/10.1159\/000536186.","journal-title":"Biomed Hub"},{"issue":"3","key":"3363_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202404391","volume":"14","author":"C Caro","year":"2025","unstructured":"Caro C, Paez-Mu\u00f1oz JM, Pern\u00eda Leal M, Carayol M, Feijoo-Cuaresma M, Garc\u00eda-Mart\u00edn ML. Metabolically-driven active targeting of magnetic nanoparticles functionalized with glucuronic acid to glioblastoma: application to MRI-tracked magnetic hyperthermia therapy. Adv Healthc Mater. 2025;14(3):e2404391. https:\/\/doi.org\/10.1002\/adhm.202404391.","journal-title":"Adv Healthc Mater"},{"key":"3363_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.molliq.2020.112759","volume":"304","author":"IC Carvalho","year":"2020","unstructured":"Carvalho IC, Mansur HS, Mansur AA, Carvalho SM, de Oliveira LCA, de Fatima Leite M. Luminescent switch of polysaccharide-peptide-quantum dot nanostructures for targeted-intracellular imaging of glioblastoma cells. J Mol Liq. 2020;304:112759. https:\/\/doi.org\/10.1016\/j.molliq.2020.112759.","journal-title":"J Mol Liq"},{"key":"3363_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2025.164308","volume":"517","author":"C Chen","year":"2025","unstructured":"Chen C, Yi R, Wang L, Huang S, Cheng X, Wang Y, et al. Metformin-based near-infrared fluorescent carbon nanotheranostic platform utilized for glioma imaging and immunotherapy. Chem Eng J. 2025;517:164308. https:\/\/doi.org\/10.1016\/j.cej.2025.164308.","journal-title":"Chem Eng J"},{"issue":"7463","key":"3363_CR11","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nature12327","volume":"500","author":"C Chen","year":"2013","unstructured":"Chen C, Ke J, Zhou XE, Yi W, Brunzelle JS, Li J, et al. Structural basis for molecular recognition of folic acid by folate receptors. Nature. 2013;500(7463):486\u20139. https:\/\/doi.org\/10.1038\/nature12327.","journal-title":"Nature"},{"key":"3363_CR12","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S549662","author":"N Chegeni","year":"2025","unstructured":"Chegeni N, Kadivar F, Saraei P. Folic acid, folate conjugates and folate receptors: novel applications in imaging of cancer and inflammation-related conditions. Cancer Manag Res. 2025. https:\/\/doi.org\/10.2147\/CMAR.S549662.","journal-title":"Cancer Manag Res"},{"issue":"7","key":"3363_CR13","doi-asserted-by":"publisher","first-page":"7292","DOI":"10.1021\/acsnano.8b03500","volume":"12","author":"A Cox","year":"2018","unstructured":"Cox A, Andreozzi P, Dal Magro R, Fiordaliso F, Corbelli A, Talamini L, et al. Evolution of nanoparticle protein corona across the blood\u2013brain barrier. ACS Nano. 2018;12(7):7292\u2013300. https:\/\/doi.org\/10.1021\/acsnano.8b03500.","journal-title":"ACS Nano"},{"issue":"4","key":"3363_CR14","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.bbamem.2008.09.016","volume":"1788","author":"MA Deli","year":"2009","unstructured":"Deli MA. Potential use of tight junction modulators to reversibly open membranous barriers and improve drug delivery. Biochim Biophys Acta Biomembr. 2009;1788(4):892\u2013910. https:\/\/doi.org\/10.1016\/j.bbamem.2008.09.016.","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"3363_CR15","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/S1474-4422(10)70181-2","volume":"9","author":"FG Dhermain","year":"2010","unstructured":"Dhermain FG, Hau P, Lanfermann H, Jacobs AH, van den Bent MJ. Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas. Lancet Neurol. 2010;9:906\u201320. https:\/\/doi.org\/10.1016\/S1474-4422(10)70181-2.","journal-title":"Lancet Neurol"},{"issue":"6","key":"3363_CR16","doi-asserted-by":"publisher","first-page":"706","DOI":"10.3390\/pharmaceutics17060706","volume":"17","author":"L Ding","year":"2025","unstructured":"Ding L, Kshirsagar P, Agrawal P, Murry DJ. Crossing the blood\u2013brain barrier: innovations in receptor-and transporter-mediated transcytosis strategies. Pharmaceutics. 2025;17(6):706. https:\/\/doi.org\/10.3390\/pharmaceutics17060706.","journal-title":"Pharmaceutics"},{"key":"3363_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2023.100671","volume":"20","author":"LD Di Filippo","year":"2023","unstructured":"Di Filippo LD, de Carvalho SG, Duarte JL, Luiz MT, Dutra JAP, de Paula GA, et al. A receptor-mediated landscape of druggable and targeted nanomaterials for gliomas. Mater Today Bio. 2023;20:100671. https:\/\/doi.org\/10.1016\/j.mtbio.2023.100671.","journal-title":"Mater Today Bio"},{"key":"3363_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.msec.2019.110341","volume":"107","author":"B Farran","year":"2020","unstructured":"Farran B, Montenegro RC, Kasa P, Pavitra E, Huh YS, Han YK, et al. Folate-conjugated nanovehicles: strategies for cancer therapy. Mater Sci Eng, C. 2020;107:110341. https:\/\/doi.org\/10.1016\/j.msec.2019.110341.","journal-title":"Mater Sci Eng, C"},{"issue":"7","key":"3363_CR19","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1007\/s12010-011-9383-z","volume":"165","author":"A Fernandez-Fernandez","year":"2011","unstructured":"Fernandez-Fernandez A, Manchanda R, McGoron AJ. Theranostic applications of nanomaterials in cancer: drug delivery, image-guided therapy, and multifunctional platforms. Appl Biochem Biotechnol. 2011;165(7):1628\u201351. https:\/\/doi.org\/10.1007\/s12010-011-9383-z.","journal-title":"Appl Biochem Biotechnol"},{"key":"3363_CR20","doi-asserted-by":"publisher","unstructured":"Fern\u00e1ndez M, Javaid F, Chudasama V. Advances in targeting the folate receptor in the treatment\/imaging of cancers, Chem. Sci. 2018; 9(4):790\u2013810. https:\/\/doi.org\/10.1039\/c7sc04004k","DOI":"10.1039\/c7sc04004k"},{"key":"3363_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpb.2020.105493","volume":"193","author":"Y Gao","year":"2020","unstructured":"Gao Y, Shi Y, Fu M, Feng Y, Lin G, Kong D, et al. Simulation study of the effects of interstitial fluid pressure and blood flow velocity on transvascular transport of nanoparticles in tumor microenvironment. Comput Methods Programs Biomed. 2020;193:105493. https:\/\/doi.org\/10.1016\/j.cmpb.2020.105493.","journal-title":"Comput Methods Programs Biomed"},{"issue":"5","key":"3363_CR22","doi-asserted-by":"publisher","first-page":"661","DOI":"10.3390\/pharmaceutics17050661","volume":"17","author":"M Gomes","year":"2025","unstructured":"Gomes M, Ramalho MJ, Loureiro JA, Pereira MC. Advancing brain targeting: cost-effective surface-modified nanoparticles for faster market entry. Pharmaceutics. 2025;17(5):661. https:\/\/doi.org\/10.3390\/pharmaceutics17050661.","journal-title":"Pharmaceutics"},{"issue":"10","key":"3363_CR23","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.3390\/cancers14102412","volume":"14","author":"S Grochans","year":"2022","unstructured":"Grochans S, Cybulska AM, Simi\u0144ska D, Korbecki J, Kojder K, Chlubek D, et al. Epidemiology of glioblastoma multiforme-literature review. Cancers. 2022;14(10):2412. https:\/\/doi.org\/10.3390\/cancers14102412.","journal-title":"Cancers"},{"issue":"12","key":"3363_CR24","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1016\/j.xphs.2017.08.009","volume":"106","author":"J Guo","year":"2017","unstructured":"Guo J, Schlich M, Cryan JF, O\u2019Driscoll CM. Targeted drug delivery via folate receptors for the treatment of brain cancer: can the promise deliver? J Pharm Sci. 2017;106(12):3413\u201320. https:\/\/doi.org\/10.1016\/j.xphs.2017.08.009.","journal-title":"J Pharm Sci"},{"issue":"9","key":"3363_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16091715","volume":"16","author":"AR Hoggarth","year":"2024","unstructured":"Hoggarth AR, Muthukumar S, Thomas SM, Crowley J, Kiser J, Witcher MR. Clinical theranostics in recurrent gliomas: a review. Cancers. 2024;16(9):1715. https:\/\/doi.org\/10.3390\/cancers16091715.","journal-title":"Cancers"},{"key":"3363_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2023.105145","volume":"90","author":"SM Honmane","year":"2023","unstructured":"Honmane SM, Charde MS, Choudhari PB, Jadhav NR. Development and in vitro evaluation of folate conjugated polydopamine modified carmustine-loaded liposomes for improved anticancer activity. J Drug Deliv Sci Technol. 2023;90:105145. https:\/\/doi.org\/10.1016\/j.jddst.2023.105145.","journal-title":"J Drug Deliv Sci Technol"},{"key":"3363_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2025.123138","volume":"318","author":"M Ismail","year":"2025","unstructured":"Ismail M, Liu J, Wang N, Zhang D, Qin C, Shi B, et al. Advanced nanoparticle engineering for precision therapeutics of brain diseases. Biomaterials. 2025;318:123138. https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123138.","journal-title":"Biomaterials"},{"key":"3363_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121608","volume":"287","author":"M Ismail","year":"2022","unstructured":"Ismail M, Yang W, Li Y, Chai T, Zhang D, Du Q, et al. Targeted liposomes for combined delivery of artesunate and temozolomide to resistant glioblastoma. Biomaterials. 2022;287:121608. https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121608.","journal-title":"Biomaterials"},{"key":"3363_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121760","volume":"289","author":"M Ismail","year":"2022","unstructured":"Ismail M, Yang W, Li Y, Wang Y, He W, Wang J, et al. Biomimetic Dp44mT-nanoparticles selectively induce apoptosis in Cu-loaded glioblastoma resulting in potent growth inhibition. Biomaterials. 2022;289:121760. https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121760.","journal-title":"Biomaterials"},{"key":"3363_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.121248","volume":"313","author":"M Kamali","year":"2023","unstructured":"Kamali M, Webster TJ, Amani A, Hadjighassem MR, Malekpour MR, Tirgar F, et al. Effect of folate-targeted Erlotinib loaded human serum albumin nanoparticles on tumor size and survival rate in a rat model of glioblastoma. Life Sci. 2023;313:121248. https:\/\/doi.org\/10.1016\/j.lfs.2022.121248.","journal-title":"Life Sci"},{"key":"3363_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.nwnano.2025.100158","author":"KG Karthikeyan","year":"2025","unstructured":"Karthikeyan KG, Venkatesan B, Vaghesan N, Selvan P, Saikumar S. Nanoplatform-based theranostics in glioblastoma: a promising frontier for precision oncology. Nano Trends. 2025. https:\/\/doi.org\/10.1016\/j.nwnano.2025.100158.","journal-title":"Nano Trends"},{"issue":"2","key":"3363_CR32","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1002\/ijc.21712","volume":"119","author":"LE Kelemen","year":"2006","unstructured":"Kelemen LE. The role of folate receptor alpha in cancer development, progression and treatment: cause, consequence or innocent bystander? Int J Cancer. 2006;119(2):243\u201350. https:\/\/doi.org\/10.1002\/ijc.21712.","journal-title":"Int J Cancer"},{"issue":"7","key":"3363_CR33","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.arabjc.2017.05.011","volume":"12","author":"I Khan","year":"2019","unstructured":"Khan I, Saeed K, Khan I. Nanoparticles: properties, applications and toxicities. Arab J Chem. 2019;12(7):908\u201331. https:\/\/doi.org\/10.1016\/j.arabjc.2017.05.011.","journal-title":"Arab J Chem"},{"issue":"1","key":"3363_CR34","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s11060-011-0738-7","volume":"107","author":"M Koshy","year":"2012","unstructured":"Koshy M, Villano JL, Dolecek TA, Howard A, Mahmood U, Chmura SJ, et al. Improved survival time trends for glioblastoma using the SEER 17 population-based registries. J Neurooncol. 2012;107(1):207\u201312. https:\/\/doi.org\/10.1007\/s11060-011-0738-7.","journal-title":"J Neurooncol"},{"issue":"10","key":"3363_CR35","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1093\/annonc\/mdv250","volume":"26","author":"JA Ledermann","year":"2015","unstructured":"Ledermann JA, Canevari S, Thigpen T. Targeting the folate receptor: diagnostic and therapeutic approaches to personalize cancer treatments. Ann Oncol. 2015;26(10):2034\u201343. https:\/\/doi.org\/10.1093\/annonc\/mdv250.","journal-title":"Ann Oncol"},{"issue":"15","key":"3363_CR36","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13153690","volume":"13","author":"YJ Lu","year":"2021","unstructured":"Lu YJ, S AT, Chuang CC, Chen JP. Liposomal IR-780 as a highly stable nanotheranostic agent for improved photothermal\/photodynamic therapy of brain tumors by convection-enhanced delivery. Cancers (Basel). 2021;13(15):3690. https:\/\/doi.org\/10.3390\/cancers13153690.","journal-title":"Cancers (Basel)"},{"issue":"2","key":"3363_CR37","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3892\/ijo.2023.5599","volume":"64","author":"C Lu","year":"2023","unstructured":"Lu C, Liu Y, Miao L, Kong X, Li H, Chen H, et al. Research progress on the role of tumor-associated macrophages in tumor development and their use as molecular targets. Int J Oncol. 2023;64(2):11. https:\/\/doi.org\/10.3892\/ijo.2023.5599.","journal-title":"Int J Oncol"},{"issue":"2","key":"3363_CR38","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s13346-020-00880-8","volume":"11","author":"E Luque-Michel","year":"2021","unstructured":"Luque-Michel E, Lemaire L, Blanco-Prieto MJ. SPION and doxorubicin-loaded polymeric nanocarriers for glioblastoma theranostics. Drug Deliv Transl Res. 2021;11(2):515\u201323. https:\/\/doi.org\/10.1007\/s13346-020-00880-8.","journal-title":"Drug Deliv Transl Res"},{"key":"3363_CR39","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.biocel.2019.01.010","volume":"108","author":"SE Minaei","year":"2019","unstructured":"Minaei SE, Khoei S, Khoee S. Tri-block copolymer nanoparticles modified with folic acid for temozolomide delivery in glioblastoma. Int J Biochem Cell Biol. 2019;108:72\u201383. https:\/\/doi.org\/10.1016\/j.biocel.2019.01.010.","journal-title":"Int J Biochem Cell Biol"},{"key":"3363_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.120729","volume":"306","author":"SE Minaei","year":"2022","unstructured":"Minaei SE, Khoei S, Khoee S, Mahdavi SR. Sensitization of glioblastoma cancer cells to radiotherapy and magnetic hyperthermia by targeted temozolomide-loaded magnetite tri-block copolymer nanoparticles as a nanotheranostic agent. Life Sci. 2022;306:120729. https:\/\/doi.org\/10.1016\/j.lfs.2022.120729.","journal-title":"Life Sci"},{"issue":"6","key":"3363_CR41","doi-asserted-by":"publisher","first-page":"4111","DOI":"10.1021\/acsomega.0c05500","volume":"6","author":"E McCord","year":"2021","unstructured":"McCord E, Pawar S, Koneru T, Tatiparti K, Sau S, Iyer AK. Folate receptors\u2019 expression in gliomas may possess potential nanoparticle-based drug delivery opportunities. ACS Omega. 2021;6(6):4111\u20138. https:\/\/doi.org\/10.1021\/acsomega.0c05500.","journal-title":"ACS Omega"},{"issue":"5","key":"3363_CR42","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11910-024-01338-x","volume":"24","author":"KH Narsinh","year":"2024","unstructured":"Narsinh KH, Perez E, Haddad AF, Young JS, Savastano L, Villanueva-Meyer JE, et al. Strategies to improve drug delivery across the blood-brain barrier for glioblastoma. Curr Neurol Neurosci Rep. 2024;24(5):123\u201339. https:\/\/doi.org\/10.1007\/s11910-024-01338-x.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"2","key":"3363_CR43","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1177\/10738584187750","volume":"25","author":"T Nakada","year":"2019","unstructured":"Nakada T, Kwee IL. Fluid dynamics inside the brain barrier: current concept of interstitial flow, glymphatic flow, and cerebrospinal fluid circulation in the brain. Neuroscientist. 2019;25(2):155\u201366. https:\/\/doi.org\/10.1177\/10738584187750.","journal-title":"Neuroscientist"},{"key":"3363_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtchem.2020.100270","volume":"16","author":"J Niskanen","year":"2020","unstructured":"Niskanen J, Zhang I, Xue Y, Golberg D, Maysinger D, Winnik FM. Dually-functionalized boron nitride nanotubes to target glioblastoma multiforme. Mater Today Chem. 2020;16:100270. https:\/\/doi.org\/10.1016\/j.mtchem.2020.100270.","journal-title":"Mater Today Chem"},{"key":"3363_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2019.101343","volume":"57","author":"J Niu","year":"2020","unstructured":"Niu J, Wang L, Yuan M, Zhang J, Chen H, Zhang Y. Dual-targeting nanocarrier based on glucose and folic acid functionalized pluronic P105 polymeric micelles for enhanced brain distribution. J Drug Deliv Sci Technol. 2020;57:101343. https:\/\/doi.org\/10.1016\/j.jddst.2019.101343.","journal-title":"J Drug Deliv Sci Technol"},{"issue":"1","key":"3363_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s42269-025-01309-3","volume":"49","author":"AK Parashar","year":"2025","unstructured":"Parashar AK, Saraogi GK, Shrivastava V, Bagri R, Tyagi LK, Sethi VA, et al. Development of Angiopep-2 targeted dendrimer-based nanotheranostic system for enhanced temozolomide delivery to glioblastoma multiforme. Bull Natl Res Cent. 2025;49(1):16. https:\/\/doi.org\/10.1186\/s42269-025-01309-3.","journal-title":"Bull Natl Res Cent"},{"key":"3363_CR47","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.jconrel.2021.05.046","volume":"335","author":"N Pathan","year":"2021","unstructured":"Pathan N, Shende P. Tailoring of P-glycoprotein for effective transportation of actives across blood-brain-barrier. J Control Release. 2021;335:398\u2013407. https:\/\/doi.org\/10.1016\/j.jconrel.2021.05.046.","journal-title":"J Control Release"},{"issue":"19","key":"3363_CR48","doi-asserted-by":"publisher","first-page":"6696","DOI":"10.3390\/molecules27196696","volume":"27","author":"AC di Polidoro","year":"2022","unstructured":"di Polidoro AC, Cafarchio A, Vecchione D, Donato P, De Nola F, Torino E. Revealing angiopep-2\/LRP1 molecular interaction for optimal delivery to glioblastoma (GBM). Molecules. 2022;27(19):6696. https:\/\/doi.org\/10.3390\/molecules27196696.","journal-title":"Molecules"},{"issue":"18","key":"3363_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241814256","volume":"24","author":"N Rabah","year":"2023","unstructured":"Rabah N, Ait Mohand FE, Kravchenko-Balasha N. Understanding glioblastoma signaling, heterogeneity, invasiveness, and drug delivery barriers. Int J Mol Sci. 2023;24(18):14256. https:\/\/doi.org\/10.3390\/ijms241814256.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"3363_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14020279","volume":"14","author":"MJ Ramalho","year":"2022","unstructured":"Ramalho MJ, Loureiro JA, Coelho MA, Pereira MC. Transferrin receptor-targeted nanocarriers: overcoming barriers to treat glioblastoma. Pharmaceutics. 2022;14(2):279. https:\/\/doi.org\/10.3390\/pharmaceutics14020279.","journal-title":"Pharmaceutics"},{"issue":"2","key":"3363_CR51","doi-asserted-by":"publisher","DOI":"10.7363\/120206","volume":"12","author":"M Rodrigues","year":"2023","unstructured":"Rodrigues M, Grilo M, Baptista MJ. Hyperosmolar therapy in pediatric traumatic brain injury: a systematic review. J Pediatr Neonatal Individ Med. 2023;12(2):e120206-e120206. https:\/\/doi.org\/10.7363\/120206.","journal-title":"J Pediatr Neonatal Individ Med"},{"issue":"4","key":"3363_CR52","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s10555-008-9155-6","volume":"27","author":"EI Sega","year":"2008","unstructured":"Sega EI, Low PS. Tumor detection using folate receptor-targeted imaging agents. Cancer Metastasis Rev. 2008;27(4):655\u201364. https:\/\/doi.org\/10.1007\/s10555-008-9155-6.","journal-title":"Cancer Metastasis Rev"},{"issue":"2","key":"3363_CR53","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/s0169-409x(99)00062-9","volume":"41","author":"J Sudimack","year":"2000","unstructured":"Sudimack J, Lee RJ. Targeted drug delivery via the folate receptor. Adv Drug Deliv Rev. 2000;41(2):147\u201362. https:\/\/doi.org\/10.1016\/s0169-409x(99)00062-9.","journal-title":"Adv Drug Deliv Rev"},{"key":"3363_CR54","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.matlet.2019.06.022","volume":"252","author":"CP Santana","year":"2019","unstructured":"Santana CP, Mansur AA, Carvalho SM, da Silva-Cunha Jr A, Mansur HS. Bi-functional quantum dot-polysaccharide-antibody immunoconjugates for bioimaging and killing brain cancer cells in vitro. Mater Lett. 2019;252:333\u20137. https:\/\/doi.org\/10.1016\/j.matlet.2019.06.022.","journal-title":"Mater Lett"},{"issue":"12","key":"3363_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/cells13120998","volume":"13","author":"E Ter Linden","year":"2024","unstructured":"Ter Linden E, Abels ER, van Solinge TS, Neefjes J, Broekman MLD. Overcoming barriers in glioblastoma-advances in drug delivery strategies. Cells. 2024;13(12):998. https:\/\/doi.org\/10.3390\/cells13120998.","journal-title":"Cells"},{"key":"3363_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfa.2022.129797","volume":"652","author":"M Torabi","year":"2022","unstructured":"Torabi M, Yaghoobi F, Shervedani RK, Kefayat A, Ghahremani F, Harsini PR. Mn (II) & Gd (III) deferrioxamine complex contrast agents & temozolomide cancer prodrug immobilized on folic acid targeted graphene\/polyacrylic acid nanocarrier: MRI efficiency, drug stability & interactions with cancer cells. Colloids Surf A Physicochem Eng Asp. 2022;652:129797. https:\/\/doi.org\/10.1016\/j.colsurfa.2022.129797.","journal-title":"Colloids Surf A Physicochem Eng Asp"},{"key":"3363_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drup.2015.02.002","volume":"19","author":"O Van Tellingen","year":"2015","unstructured":"Van Tellingen O, Yetkin-Arik B, De Gooijer MC, Wesseling P, Wurdinger T, De Vries HE. Overcoming the blood\u2013brain tumor barrier for effective glioblastoma treatment. Drug Resist Updat. 2015;19:1\u201312. https:\/\/doi.org\/10.1016\/j.drup.2015.02.002.","journal-title":"Drug Resist Updat"},{"key":"3363_CR58","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ab.2016.08.010","volume":"512","author":"X Wang","year":"2016","unstructured":"Wang X, Tu M, Tian B, Yi Y, Wei Z, Wei F. Synthesis of tumor-targeted folate conjugated fluorescent magnetic albumin nanoparticles for enhanced intracellular dual-modal imaging into human brain tumor cells. Anal Biochem. 2016;512:8\u201317. https:\/\/doi.org\/10.1016\/j.ab.2016.08.010.","journal-title":"Anal Biochem"},{"key":"3363_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2025.114472","author":"N Wang","year":"2025","unstructured":"Wang N, Qing Q, Xue Y, Cai S, Zheng M, Zhang D, et al. Enhancing lipid nanoparticles-mediated RNA delivery to glioblastoma via targeted strategies. J Control Release. 2025. https:\/\/doi.org\/10.1016\/j.jconrel.2025.114472.","journal-title":"J Control Release"},{"key":"3363_CR60","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S531451","author":"K Wang","year":"2025","unstructured":"Wang K, Sun J, Zhao H, Wang F, Zhang X, Zhao X, et al. Advances and challenges in nano-delivery systems for glioblastoma treatment: a comprehensive review. Int J Nanomedicine. 2025. https:\/\/doi.org\/10.2147\/IJN.S531451.","journal-title":"Int J Nanomedicine"},{"issue":"4","key":"3363_CR61","doi-asserted-by":"publisher","DOI":"10.1117\/1.2764463","volume":"12","author":"J Wang","year":"2007","unstructured":"Wang J, Yong WH, Sun Y, Vernier PT, Koeffler HP, Gundersen MA, et al. Receptor-targeted quantum dots: fluorescent probes for brain tumor diagnosis. J Biomed Opt. 2007;12(4):044021. https:\/\/doi.org\/10.1117\/1.2764463.","journal-title":"J Biomed Opt"},{"issue":"1","key":"3363_CR62","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41392-023-01481-w","volume":"8","author":"D Wu","year":"2023","unstructured":"Wu D, Chen Q, Chen X, Han F, Chen Z, Wang Y. The blood-brain barrier: structure, regulation, and drug delivery. Signal Transduct Target Ther. 2023;8(1):217. https:\/\/doi.org\/10.1038\/s41392-023-01481-w.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"3363_CR63","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40880-015-0064-0","volume":"35","author":"P Xing","year":"2016","unstructured":"Xing P, Liao Z, Ren Z, Zhao J, Song F, Wang G, et al. Roles of low-density lipoprotein receptor-related protein 1 in tumors. Chin J Cancer. 2016;35(1):6. https:\/\/doi.org\/10.1186\/s40880-015-0064-0.","journal-title":"Chin J Cancer"},{"key":"3363_CR64","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jconrel.2017.02.023","volume":"252","author":"L Xu","year":"2017","unstructured":"Xu L, Bai Q, Zhang X, Yang H. Folate-mediated chemotherapy and diagnostics: an updated review and outlook. J Control Release. 2017;252:73\u201382. https:\/\/doi.org\/10.1016\/j.jconrel.2017.02.023.","journal-title":"J Control Release"},{"issue":"7","key":"3363_CR65","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.3390\/cancers15072116","volume":"15","author":"SSK Yalamarty","year":"2023","unstructured":"Yalamarty SSK, Filipczak N, Li X, Subhan MA, Parveen F, Ataide JA, et al. Mechanisms of resistance and current treatment options for glioblastoma multiforme (GBM). Cancers. 2023;15(7):2116. https:\/\/doi.org\/10.3390\/cancers15072116.","journal-title":"Cancers"},{"key":"3363_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2022.116893","volume":"69","author":"C Yang","year":"2022","unstructured":"Yang C, Yang Z, Wang S, Chen J, Liu Q, Huang T, et al. Berberine and folic acid co-modified pH-sensitive cascade-targeted PTX-liposomes coated with Tween 80 for treating glioma. Bioorg Med Chem. 2022;69:116893. https:\/\/doi.org\/10.1016\/j.bmc.2022.116893.","journal-title":"Bioorg Med Chem"},{"key":"3363_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.indcrop.2025.121704","volume":"235","author":"J Zhang","year":"2025","unstructured":"Zhang J, Zhan B, Du Y, Liu N, Liu S, Li X. Targeted cancer treatment using folic acid-functionalized carbohydrate polymers: a new era in nanomedicine. Ind Crops Prod. 2025;235:121704. https:\/\/doi.org\/10.1016\/j.indcrop.2025.121704.","journal-title":"Ind Crops Prod"},{"key":"3363_CR68","doi-asserted-by":"publisher","DOI":"10.2147\/IJN.S77667","author":"L Zhang","year":"2015","unstructured":"Zhang L, Zhu D, Dong X, Sun H, Song C, Wang C, et al. Folate-modified lipid\u2013polymer hybrid nanoparticles for targeted paclitaxel delivery. Int J Nanomed. 2015. https:\/\/doi.org\/10.2147\/IJN.S77667.","journal-title":"Int J Nanomed"},{"issue":"3","key":"3363_CR69","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.7150\/thno.38147","volume":"10","author":"M Zhao","year":"2020","unstructured":"Zhao M, van Straten D, Broekman MLD, Pr\u00e9at V, Schiffelers RM. Nanocarrier-based drug combination therapy for glioblastoma. Theranostics. 2020;10(3):1355\u201372. https:\/\/doi.org\/10.7150\/thno.38147.","journal-title":"Theranostics"},{"issue":"1","key":"3363_CR70","doi-asserted-by":"publisher","DOI":"10.3402\/nano.v3i0.18496","volume":"3","author":"GL Zwicke","year":"2012","unstructured":"Zwicke GL, Mansoori GA, Jeffery CJ. Utilizing the folate receptor for active targeting of cancer nanotherapeutics. Nano Rev. 2012;3(1):18496. https:\/\/doi.org\/10.3402\/nano.v3i0.18496.","journal-title":"Nano Rev"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03363-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03363-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-026-03363-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:41:40Z","timestamp":1792096900000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12032-026-03363-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,15]]},"references-count":70,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["3363"],"URL":"https:\/\/doi.org\/10.1007\/s12032-026-03363-x","relation":{},"ISSN":["1559-131X"],"issn-type":[{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,15]]},"assertion":[{"value":"20 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author(s) declare that they have no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was not required for this study.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"283"}}